RESULTS: During the study period, 1217 cases and 22 deaths due to pediatric neuroinvasive arboviral infection were reported from the 48 contiguous states. La Crosse virus (665 cases; 55%) and West Nile virus (505 cases; 41%) were the most common etiologies identified. Although less common, Eastern equine encephalitis virus (30 cases; 2%) resulted in 10 pediatric deaths. La Crosse virus primarily affected younger children, whereas West Nile virus was more common in older children and adolescents. West Nile virus disease cases occurred throughout the country, whereas La Crosse and the other arboviruses were more focally distributed.
CONCLUSIONS: Neuroinvasive arboviral infections were an important cause of pediatric disease from 2003 through 2012. Differences in the epidemiology and clinical disease result from complex interactions among virus, vector, host, and the environment. Decreasing the morbidity and mortality from these agents depends on vector control, personal protection to reduce mosquito and tick bites, and blood donor screening. Effective surveillance is critical to inform clinicians and public health officials about the epidemiologic features of these diseases and to direct prevention efforts. Pediatrics 2014;134:e642-e650
Arthropod-borne viruses (arboviruses) are transmitted to humans primarily through the bites of infected mosquitoes or ticks. Most human arboviral infections are asymptomatic. Symptomatic infections most often manifest as a systemic febrile illness and, less commonly, as neuroinvasive disease (meningitis, encephalitis, or acute flaccid paralysis). Because of the considerable morbidity associated with neuroinvasive disease, case detection and reporting is assumed to be more consistent and complete than for nonneuroinvasive disease. 1 West Nile virus is the leading cause of arboviral disease in the United States. 2 However, La Crosse virus infections occur primarily among children and several other arboviruses (eg, Eastern equine encephalitis, St Louis encephalitis, and Powassan viruses) cause sporadic cases and seasonal outbreaks. 2, 3 Domestic neurotropic arboviruses belong to 3 virus families (ie, Bunyaviridae, Flaviviridae, and Togaviridae). Different vectors, animal hosts, and tissue tropisms contribute to variations in geographic distribution, disease incidence, clinical manifestations, and outcomes. Understanding the epidemiology and burden of arboviral disease is essential to directing diagnostic testing and improving public health control efforts. We describe the epidemiology of neuroinvasive arboviral infections among children in the United States from 2003 through 2012.
METHODS

Case Definitions and Reporting
We defined a case as a child (,18 years of age) with domestically acquired neuroinvasive arboviral disease in the United States from 2003 through 2012. Cases were identified from reports to ArboNET, the national arboviral surveillance system. Human disease due to Eastern equine encephalitis virus, La Crosse and other California serogroup viruses, Powassan virus, St Louis encephalitis virus, Western equine encephalitis virus, and West Nile virus are nationally notifiable conditions. 4 State health departments report arboviral disease cases to US Centers for Disease Control and Prevention (CDC) through ArboNET by using standard surveillance case definitions that include clinical and laboratory criteria. 4 Laboratory confirmation may be performed by viral culture, nucleic acid amplification, immunohistochemical staining, or serology, but the specific tests used to confirm each case are not reported to ArboNET. All confirmed and probable cases were included.
Data routinely collected in ArboNET include patient age, gender, county and state of residence, date of illness onset, case status (ie, confirmed, probable, suspect, or not a case), clinical syndrome (eg, meningitis, encephalitis, acute flaccid paralysis, uncomplicated fever), and outcome (hospitalization or fatality). Cases reported as meningitis, encephalitis, or acute flaccid paralysis were classified as neuroinvasive disease; others were considered nonneuroinvasive disease. Cases reported as meningoencephalitis were classified as encephalitis; cases reported as acute flaccid paralysis (with or without another clinical syndrome) were classified as acute flaccid paralysis only and not included in the other clinical syndrome categories. Information regarding hospitalization and acute flaccid paralysis was collected starting in 2004. A previous publication describing the epidemiology of neuroinvasive arboviral disease in the United States from 1999 to 2007 included 4 years of data presented here but did not focus on pediatric disease. 3
Data Analysis
We described the number of reported cases and calculated national incidence per 1 000 000 children by using US Census Bureau annual population estimates. [5] [6] [7] County-level incidences were calculated by using 2010 census data. 8 Categorical variables were summarized using counts and proportions; continuous variables were summarized by using median and range. Statistical analyses were performed using Stata version 11.2 (Stata Corp, College Station, TX). Maps were generated by using ArcGIS version 10.1 (ESRI, Redlands, CA). Table 2 ). The median age of patients was 12 years (range: 1 month-17 years) and 173 (34%) were 15 to 17 years of age ( Fig 3) . Cases peaked in August, with 444 (88%) having illness onset during July through September (Fig 4) . Half of the cases (n = 295) were classified as meningitis, 236 (47%) as encephalitis, and 14 (3%) as acute flaccid paralysis; 7 (50%) of the patients with acute flaccid paralysis also had meningitis or encephalitis ( Table 2 ). Three patients (1%) died. Of the 356 cases with available data, 312 (88%) were hospitalized.
RESULTS
La Crosse Virus
Over the 10-year period, 754 La Crosse virus neuroinvasive disease cases were reported to the CDC (Table 1) . Most (665 cases, 88%) occurred in children La Crosse virus neuroinvasive disease cases were reported from 204 counties in 21 states ( Fig 2B) . States with the highest average annual incidence rates were in the Appalachian and Midwestern regions, including West Virginia (37.69 per million children), Tennessee (6.28), North Carolina (6.22), and Ohio (5.86). Those 4 states reported 81% of all cases: Ohio (160 cases), West Virginia (146), North Carolina (142), and Tennessee (94). Furthermore, 372 (56%) of the 665 cases reported nationally occurred in residents of just 29 (9%) of the 336 counties in these 4 states (10 counties in central Ohio, 8 in southern West Virginia, 7 in western North Carolina, and 4 in eastern Tennessee); the median average annual incidence in these 28 counties was 91.65 cases per million children (range 2.16-309.07).
Of the 665 pediatric La Crosse virus disease cases, 412 (62%) were boys ( Table 2 ). The median age of patients was 7 years (range 1 month-17 years) and 309 (46%) were 5 to 9 years of age (Fig 3) . Although most cases (544; 82%) had illness onset during July through September, 56 (8%) occurred in June and 54 (8%) had onset in October (Fig 4) . Most cases (521; 78%) were classified as encephalitis; 134 (20%) were classified as meningitis and 10 (2%) as acute flaccid paralysis ( and lowest from 2006 through 2011 (Fig 1) .
Cases were reported from 25 counties in 11 states along the Atlantic and Gulf Coasts ( Fig 2C) Fig 2D) . Six (75%) of the pediatric casepatients were boys and their median age was 6 years (range 3 months-14 years) ( Table 2 ). Five (63%) cases had onset during the spring, whereas 2 (38%) occurred during summer. Six (75%) were classified as encephalitis; 7 (88%) were hospitalized and there were no deaths.
St Louis Encephalitis Virus
Although 109 cases of neuroinvasive disease caused by St Louis encephalitis virus were reported from 2003 through 2012, only 4 (4%) cases occurred in children, with 2 cases in 2007 and 2 cases in 2009 (Table 1) . Cases were reported from 4 counties in 3 states (Arkansas, Louisiana, and Texas). All 4 cases were classified as encephalitis; all were hospitalized but there were no deaths.
DISCUSSION
Neurotropic arboviruses have been a significant cause of pediatric disease over the past 10 years in the United States, with more than 1200 cases of central nervous system infection and 22 resulting deaths reported. La Crosse and West Nile viruses were the most important etiologies of pediatric neuroinvasive arboviral disease during this period, with incidence rates of 0.90 and 0.68 cases per million, respectively. Although the number of cases was low, Eastern equine encephalitis virus had the highest case-fatality rate, consistent with previous reports. 3, 9, 10 These differences in epidemiology and clinical disease result from complex interactions among virus, vector, host, and the environment. 3, 11, 12 It is difficult to compare the incidence rates for neuroinvasive arboviral disease with that of herpes simplex virus or enterovirus, as the latter are not nationally notifiable conditions. For herpes simplex virus, researchers estimate there are 750 encephalitis cases among neonates and another 400 cases in older children each year in the United States. [13] [14] [15] Other researchers have speculated there are at least 75 000 cases of enteroviral meningitis annually in the United States among all age groups but there are limited empirical data and the incidence in children is not known. 16, 17 Our results confirm that La Crosse virus neuroinvasive infection is predominantly a pediatric disease. Almost 90% of reported cases occur in children, particularly those younger than 10 years of age. 3 In contrast, ,4% of reported West Nile virus neuroinvasive disease cases occurred in children, and we observed a higher rate in adolescents than in younger children. Previous reports also have shown that West Nile virus disease incidence and severity were highest among older adults. 1, 3, [18] [19] [20] [21] The predilection of La Crosse virus to affect younger children is incompletely understood. Mouse models of La Crosse virus infection have correlated young age with a higher initial viremia, which is thought to be a critical factor for neuroinvasion, and age appears to be a critical factor for control of viral dissemination after direct central nervous system inoculation. 22 Although the reasons for higher incidence and severity of West Nile virus neuroinvasive disease in older age groups are not fully understood, possible explanations include changes in innate and adaptive immune function resulting in increased duration and magnitude of viremia or enhanced viral entry into the central nervous system due to disruption of the cerebral endothelium from conditions such as hypertension and cerebrovascular disease. 23, 24 La Crosse virus, an orthobunyavirus, is transmitted by Aedes triseriatus, a mosquito that lives and breeds in the water holes of trees and other vessels, with gray squirrels and chipmunks serving as primary amplifying hosts. 12 Accordingly, La Crosse virus has been reported in distinct geographic regions with wooded areas that support its transmission cycle. From 1963 to 1981, the vast majority of cases reported were from the upper Midwest. 25 Our data confirm more recent observations that the highest burden of La Crosse virus disease has now shifted to the Appalachian region of West Virginia, Tennessee, North Carolina, and Ohio. [26] [27] [28] West Nile virus, a flavivirus, is transmitted primarily by Culex mosquitoes, with birds as its natural reservoir. 23, 29 This virus now affects children from all regions of the contiguous United States, demonstrating less specificity for particular ecologic and geographic regions than other arboviral etiologies. Nevertheless, the higher incidence of disease in the northern plains and mountain regions is likely in part because of the predominance of Culex tarsalis as the primary vector in the region, and the convergence of zoonotic hosts and ecologic conditions that promote efficient amplification and transmission. 30, 31 Similarly, large outbreaks in Arizona in 2010 and north Texas in 2012 were likely due to a confluence of favorable weather and environmental conditions resulting in an abundance of susceptible vertebrate hosts and vector mosquitoes. [32] [33] [34] [35] [36] [37] Eastern equine encephalitis virus is an alphavirus. It is maintained in enzootic cycle between birds and mosquitoes by Culiseta melanura, which breeds in a specific hardwood swamp environment. 12 Several mosquito species function as bridge vectors, transmitting the virus from birds to humans and other mammals. Accordingly, human disease cases occur in limited geographic areas, mostly along the Atlantic and Gulf Coasts.
Powassan virus is unique among the reportable viruses in that it is transmitted by Ixodes ticks, rather than mosquitoes, and small woodland mammals as serve as the major environmental reservoir. 12 From 2001 to 2012, a total of 47 cases of neuroinvasive Powassan virus disease were reported in the United States. Most were classified as encephalitis and ∼10% of cases were fatal. [38] [39] [40] Pediatric Powassan virus neuroinvasive disease cases were limited to Minnesota, New York, and Wisconsin. Historically, the virus was known to occur in the northeastern United States and Canada and parts of Russia, but is increasingly being identified in the upper Midwest. 39, 40 Few St Louis encephalitis virus disease cases were reported during the surveillance period. Historically, St Louis encephalitis virus disease occurred in intermittent epidemics every 10 to 20 years and recent patterns also may reflect normal fluctuations. 3 However, there is some evidence that birds infected with West Nile virus develop cross-reactive immunity, leading to speculation that West Nile virus may competitively displace St Louis encephalitis virus by reducing the numbers of susceptible zoonotic hosts. 41, 42 Seasonal and geographic patterns of arboviral diseases are largely driven by their ecology. The vast majority of mosquito-borne disease cases were reported during the summer months corresponding to the peaks in the vector populations, viral amplification in zoonotic hosts, and human activity outdoors. 43 [51] [52] [53] However, most of these data were derived from adult blood donors and there are not similar estimates for non-neuroinvasive West Nile virus disease in children or for non-neuroinvasive disease caused by other arboviruses. In addition, preconceptions about arboviral disease epidemiology may impact diagnostic practices, with La Crosse virus testing more likely to be performed on children in selected states and West Nile virus testing considered more in older adults. 54 Additionally, because ArboNET does not routinely collect information regarding clinical signs and symptoms or specific laboratory findings (eg, cerebrospinal fluid findings), misclassification as neuroinvasive disease or a specific clinical syndrome (ie, meningitis, encephalitis, or acute flaccid paralysis) cannot be detected. For example, spinal cord involvement resulting in acute flaccid paralysis has only rarely been described with La Crosse virus or other orthobunyaviruses but 10 cases of acute flaccid paralysis were reported after La Crosse virus infections in our series. [25] [26] [27] [28] [55] [56] [57] [58] [59] [60] This finding should prompt further investigation to determine if these cases were classified as acute flaccid paralysis due to generalized weakness or true spinal cord infection.
CONCLUSIONS
This report confirms that La Crosse virus, West Nile virus, and other arboviruses are important causes of central nervous system infections among children in the United States. Outbreaks are unpredictable and result from a complex interaction among virus, vector, host, and environmental factors. These variables are dynamic because of changes in weather and ecology, demographic shifts in human populations, and the introduction and evolution of new viruses. There are no specific vaccines or therapeutics for domestic arboviral diseases. Decreasing the morbidity and mortality from these agents depends on vector control, personal protection to reduce mosquito and tick bites, and blood donor screening. Effective surveillance is critical to direct these prevention efforts. Understanding the epidemiology, seasonality, and geographic distribution of these viruses will assist with clinical recognition, development of vaccines and therapeutics, and implementation of public health preventive measures.
